Elisabeth B. Lucassen MD

Physician

30 Hope DrSte 1300Hershey, PA 17033
Phone+1 717-531-3828
Fax+1 717-531-4694

Dr. Lucassen is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lucassen's full profile Already have an account?

Education & Training

University of Rochester Medical CenterResidency, Neurology, 2007 - 2011
Pennsylvania State University College of MedicineClass of 2007

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OR State Medical License 2017 - 2023
PA State Medical License 2011 - 2018

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Cerner Sentinel Cloud Auditing, Cerner Corporation, 2014, 2017
CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2014, 2017
CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2014, 2017

Publications & Presentations

PubMed

4 citations
Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses.
Mitzi J Williams, Lilyana Amezcua, Stanley L Cohan, Jeffrey A Cohen, Silvia R Delgado
Neurology. 2024-08-13
4 citations
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab.
Amit Bar-Or, Rany Aburashed, Angel R Chinea, Barry A Hendin, Elisabeth Lucassen
Multiple Sclerosis and Related Disorders. 2023-11-01
4 citations
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis.
John Kramer, Ralf Linker, David Paling, Adam Czaplinski, Olaf Hoffmann
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2023-10-10